Evidence map›Paper›PMID 38179215›Full record

ArticleWorld journal of stem cells2023

Human mesenchymal stem cells exhibit altered mitochondrial dynamics and poor survival in high glucose microenvironment.

Ejlal Abu-El-Rub, Fatimah Almahasneh, Ramada R Khasawneh, Ayman Alzu'bi, Doaa Ghorab, Rawan Almazari, Huthaifa Magableh, Ahmad Sanajleh, Haitham Shlool, Mohammad Mazari and 2 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of stem cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Ejlal Abu-El-RubDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan. ejlal.abuelrub@yu.edu.jo.
Fatimah AlmahasnehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Ramada R KhasawnehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Ayman Alzu'biDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Doaa GhorabDepartment of Pathology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Rawan AlmazariDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Huthaifa MagablehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Ahmad SanajlehDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Haitham ShloolDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Mohammad MazariDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid 21163, Jordan.
Noor S BaderDepartment of Basic Medical Sciences, Yarmouk University, Irbid 21163, Jordan.
Joud Al-MomaniDepartment of Basic Medical Sciences, Yarmouk University, Irbid 21163, Jordan.
Yarmouk University · JOMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesenchymal stem cells (MSCs) are a type of stem cells that possess relevant regenerative abilities and can be used to treat many chronic diseases. Diabetes mellitus (DM) is a frequently diagnosed chronic disease characterized by hyperglycemia which initiates many multisystem complications in the long-run. DM patients can benefit from MSCs transplantation to curb down the pathological consequences associated with hyperglycemia persistence and restore the function of damaged tissues. MSCs therapeutic outcomes are found to last for short period of time and ultimately these regenerative cells are eradicated and died in DM disease model.

aimTo investigate the impact of high glucose or hyperglycemia on the cellular and molecular characteristics of MSCs.

methodsHuman adipose tissue-derived MSCs (hAD-MSCs) were seeded in low (5.6 mmol/L of glucose) and high glucose (25 mmol/L of glucose) for 7 d. Cytotoxicity, viability, mitochondrial dynamics, and apoptosis were deplored using specific kits. Western blotting was performed to measure the protein expression of phosphatidylinositol 3-kinase (PI3K), TSC1, and mammalian target of rapamycin (mTOR) in these cells.

resultshAD-MSCs cultured in high glucose for 7 d demonstrated marked decrease in their viability, as shown by a significant increase in lactate dehydrogenase (

conclusionHigh glucose impaired the mitochondrial dynamics and regulatory proteins in hAD-MSCs ensuing their poor survival and high apoptosis rate in hyperglycemic microenvironment.

Indexed as

ApoptosisHigh glucoseMesenchymal stem cellsMitochondrial dynamicsPhosphatidylinositol 3-kinase/mammalian target of rapamycin pathwayPoor survival

Identifiers

PMID38179215
PMCPMC10762524
OpenAlexW4390197507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.